M1483 – Patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period

HCPCS Level II code · M codes: Medical Services and Quality Measures

Active code Carrier judgment

HCPCS codeM1483
Long description
Patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period
Short description
Neg quan hep c or qual rna
Pricing indicator
00 Not separately priced by Part B (bundled, not covered or Part A only)
Medicare coverage
C Carrier judgment – coverage decided by the Medicare contractor
BETOS category
Z2 Undefined codes
Added
January 1, 2026
Last change
January 1, 2026 – No change

Frequently asked questions

What is HCPCS code M1483?

M1483 is a HCPCS Level II code for patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period.

Does Medicare cover M1483?

The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.

Nearby M codes

Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.